Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
COMMENTARIES
Dietary microbial modulation for colorectal
cancer prevention in the Hong Kong Chinese
population
Winnie YY Lin, MS, RDN; Siew C Ng, PhD, MB, BS; Francis KL Chan, DSc, MD
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong
Corresponding author: Prof Francis KL Chan (fklchan@cuhk.edu.hk)
Colorectal cancer (CRC) is one of the most common
malignancies worldwide.1 A higher incidence of
CRC is observed in more developed regions than
under developed regions, and changes in lifestyle
and dietary habits are believed to attribute to this
increased incidence.1 In Hong Kong, CRC has been
the most common cancer since 2013, with more than
5000 new diagnoses annually.2 The dietary habits
of people in Hong Kong have changed from the
traditional Chinese diet to include more fast food
and processed food with less diversity. Although the
association between microbiota and the risk of CRC
is indistinct, the undoubted fact is that patients with
CRC have less diverse microbiota than their healthy
counterparts.3 In this commentary, we discuss the
potential benefits of resuming a traditional Chinese
diet to mitigate microbial risk in CRC in the Hong
Kong Chinese population.
Microbial risk in developing
colorectal cancer
Most microbial species in the gastrointestinal tract
belong to Firmicutes, Bacteroidetes, Proteobacteria,
and Actinobacteria species. Gut microbiota form a
highly complex ecosystem composed of thousands
of species and strains which interact with one
another, the substrates, and the host. A patient’s
risk for CRC may be determined through microbial
profiling, with recent evidence showing that altered
microbiome environment, or dysbiosis, in the gut
and pathogenic bacterial colonies overgrowth has
implications for cancer development.4 5 Some gut
microbiomes—known as CRC microbial markers—have been identified as promoting colorectal
tumorigenesis.5 Certain unfavourable bacteria,
including Fusobacterium nucleatum, Escherichia
coli, Bacteroides fragilis, Clostridium hathewayi,
and Bacteroides clarus have been identified to be
more abundant in patients with CRC,6 7 whereas
beneficial bacteria are less abundant.8 Moreover,
dysbiosis is observed in patients with CRC, among
a cluster of chronic diseases, such as, inflammatory
bowel disease, diabetes mellitus, and obesity.9 10
The commonality among these diseases is chronic
inflammation, which is an important factor in the development of CRC. Some microbiomes induce
inflammation via lipopolysaccharides, whereas
others are correlated with elevated serum C-reactive
protein.11 Whatever the cause of the change
in microbiota, the abnormality in composition
is a potentially important aetiological factor in
the initiation and progression of CRC, and diet is
undeniably a key player.12
Westernisation is a global
phenomenon
The American Institute for Cancer Research and
the World Cancer Fund13 recommend a diet that is
high in fibre, rich in whole grains, and has little or
no red meat or processed meat to reduce the risk
of cancer development. In contrast, contemporary
diets in Hong Kong and other developed regions
are low in fibre, high in processed foods including
food additives, refined sugar, and hydrogenated
fats.14 15 In a study comparing the cancer risk in
rural Africans with that in African Americans, the
higher fibre, lower animal fat, and lower protein
in the rural African diet were associated with
reduced cancer risk.16 17 Ou et al16 also reported that
microbial metabolites moderated by dietary intake
can influence CRC risk. Nevertheless, different
dietary components may have various effects on
CRC risk. The current literature on microbial-diet-host
interaction is diverse and includes metabolic
cross-feeding of microbes, substrate degradation
of dietary fibres, and microbiome as moderators of
host physiology and behaviour.18
Traditional Chinese diet
One dietary approach in lowering CRC risk
involves restoring beneficial gut microbiota, thus
strengthening intestinal barrier against pathogenic
bacteria, increasing intestinal motility, and lowering
a pro-inflammatory state.19 20 This can be achieved by
adopting a diversified diet such as the Mediterranean
diet, which is high in vegetables and legumes; high
in fruits; high in grains; moderate in plant protein
rather than animal protein; and moderate in dairy.
The traditional Chinese diet shares some of these characteristics. Woo et al14 found that the dietary
habits of the Chinese population in four major cities,
evaluated using the Mediterranean Diet Score,
were compatible with, if not closer to adhering to,
the Mediterranean diet than those of the Greek
population. The authors found that cuisines varied
yet remained culturally distinctive, and the only sub-populations
in Hong Kong with less adherence to
the Mediterranean diet were the younger generation
and men, with 50% and 51%, respectively, achieving
a high Mediterranean Diet Score.14 The authors
also found that the Mediterranean Diet Score was
indicative of the preservation of traditional Chinese
dietary habit, with scores of at least 80% from a rural
Chinese population.14
Conclusion
Hippocrates once said, “All disease begins in the gut.” Although not completely true, the trillions of
microbes that live on our skin and within our body
are crucial to human health. Although there is a lack
of definitive causation between microbiota and CRC,
the synergetic effect of a diversified diet can improve
the overall anti-inflammatory prospects of the host
and promote a healthy gut by creating a balanced
microbiome. With further mechanistic studies to
understand the multi-axial microbial-diet-host
interaction, we hope to deduce a microbiota-driven
dietary recommendation decision tree to optimise
the growth and balance of gut microbiota.
Author contributions
Concept or design: WYY Lin.
Acquisition of data: WYY Lin.
Analysis or interpretation of data: WYY Lin.
Drafting of the manuscript: WYY Lin.
Critical revision of the manuscript for important intellectual content: SC Ng and FKL Chan.
Acquisition of data: WYY Lin.
Analysis or interpretation of data: WYY Lin.
Drafting of the manuscript: WYY Lin.
Critical revision of the manuscript for important intellectual content: SC Ng and FKL Chan.
All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
Conflicts of interest
All authors have disclosed no conflicts of interest.
Funding/support
This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
References
1. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance
of trends in cancer survival 2000-14 (CONCORD-3):
analysis of individual records for 37 513 025 patients
diagnosed with one of 18 cancers from 322 population-based
registries in 71 countries. Lancet 2018;391:1023-75.Crossref
2. Wong KH. Overview of Hong Kong Cancer Statistics of 2018. Hong Kong Cancer Registry. Available from: https://www3.ha.org.hk/cancereg/pdf/overview/Overview%20of%20HK%20Cancer%20Stat%202018.pdf. Accessed 6 Apr 2022.
3. Ahn J, Sinha R, Pei Z, et al. Human gut microbiome and risk
for colorectal cancer. J Natl Cancer Inst 2013;105:1907-11. Crossref
4. Cozen W, Yu Y, Hwang A, et al. Association between fecal
microbiome and colon adenomas and hyperplastic polyps
in monozygotic twins. Twin Res Hum Genet 2017;20:620.
5. Yang Y, Li L, Xu C, et al. Cross-talk between the gut
microbiota and monocyte-like macrophages mediates
an inflammatory response to promote colitis-associated
tumourigenesis. Gut 2020;70:1495-506. Crossref
6. Sears CL, Garrett WS. Microbes, microbiota, and colon
cancer. Cell Host Microbe 2014;15:317-28. Crossref
7. Liang Q, Chiu J, Chen Y, et al. Fecal bacteria act as novel
biomarkers for noninvasive diagnosis of colorectal cancer.
Clin Cancer Res 2017;23:2061-70. Crossref
8. Yu J, Feng Q, Wong SH, et al. Metagenomic analysis of
faecal microbiome as a tool towards targeted non-invasive
biomarkers for colorectal cancer. Gut 2017;66:70-8. Crossref
9. Ijaz UZ, Quince C, Hanske L, et al. The distinct features of
microbial ‘dysbiosis’ of Crohn’s disease do not occur to the
same extent in their unaffected, genetically-linked kindred.
PLoS One 2017;12:e0172605. Crossref
10. Jurjus A, Eid A, Kattar SA, et al. Inflammatory bowel
disease, colorectal cancer and type 2 diabetes mellitus: the
links. BBA Clin 2016;5:16-24. Crossref
11. Umoh FI, Kato I, Ren J, et al. Markers of systemic exposures
to products of intestinal bacteria in a dietary intervention
study. Eur J Nutr 2016;55:793-8. Crossref
12. Irrazábal T, Belcheva A, Girardin SE, Martin A, Philpott DJ.
The multifaceted role of the intestinal microbiota in colon
cancer. Mol Cell 2014;54:309-20. Crossref
13. Clinton SK, Giovannucci EL, Hursting SD. The World
Cancer Research Fund/American Institute for Cancer
Research Third Expert Report on diet, nutrition, physical
activity, and cancer: impact and future directions. J Nutr
2020;150:663-71. Crossref
14. Woo J, Woo KS, Leung SS, et al. The Mediterranean score
of dietary habits in Chinese populations in four different
geographical areas. Eur J Clin Nutr 2001;55:215-20. Crossref
15. Jew S, AbuMweis SS, Jones PJ. Evolution of the human
diet: linking our ancestral diet to modern functional foods
as a means of chronic disease prevention. J Med Food
2009;12:925-34. Crossref
16. Ou J, Carbonero F, Zoetendal EG, et al. Diet, microbiota,
and microbial metabolites in colon cancer risk in rural
Africans and African Americans. Am J Clin Nutr
2013;98:111-20. Crossref
17. O’Keefe SJ, Li JV, Lahti L, et al. Fat, fibre and cancer risk
in African Americans and rural Africans. Nat Commun
2015;6:6342. Crossref
18. Henriques SF, Dhakan DB, Serra L, et al. Metabolic cross-feeding
in imbalanced diets allows gut microbes to improve
reproduction and alter host behaviour. Nat Commun
2020;11:4236. Crossref
19. Gutiérrez-Díaz I, Fernández-Navarro T, Sánchez B,
Margolles A, González S. Mediterranean diet and faecal
microbiota: a transversal study. Food Funct 2016;7:2347-56. Crossref
20. De Filippis F, Pellegrini N, Vannini L, et al. High-level
adherence to a Mediterranean diet beneficially impacts
the gut microbiota and associated metabolome. Gut
2016;65:1812-21. Crossref